CNTX Context Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CNTX

Price (delayed)

$0.3826

Market cap

$35.15M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.48

Enterprise value

-$7.59M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 2
Highlights
CNTX's debt is up by 46% year-on-year but it is down by 13% since the previous quarter
The quick ratio has shrunk by 70% YoY and by 35% QoQ
The equity has dropped by 54% year-on-year and by 27% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.contexttherapeutics.com
Peers: VRTX NTLA CRSP EDIT

Key stats

What are the main financial stats of CNTX

CNTX stock price

How has the Context Therapeutics stock price performed over time
Intraday
-1.67%
1 week
0.95%
1 month
-23.5%
1 year
-60.61%
YTD
-73.97%
QTD
-30.93%

Financial performance

How have Context Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$48.41M
Net income
-$45.96M
Gross margin
N/A
Net margin
N/A
Context Therapeutics's net income has decreased by 34% YoY and by 14% from the previous quarter
CNTX's operating income is down by 26% year-on-year and by 12% since the previous quarter

Price vs fundamentals

How does CNTX's price correlate with its fundamentals

Growth

What is Context Therapeutics's growth rate over time

Valuation

What is Context Therapeutics stock price valuation
P/E
N/A
P/B
0.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
CNTX's EPS is down by 33% year-on-year and by 14% since the previous quarter
CNTX's P/B is 59% lower than its last 4 quarters average of 2.3 and 28% lower than its 5-year quarterly average of 1.3
The equity has dropped by 54% year-on-year and by 27% since the previous quarter

Efficiency

How efficient is Context Therapeutics business performance
CNTX's ROE has dropped by 112% year-on-year and by 37% since the previous quarter
The ROA has shrunk by 94% YoY and by 33% QoQ

Dividends

What is CNTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CNTX.

Financial health

How did Context Therapeutics financials performed over time
CNTX's total liabilities has soared by 73% year-on-year and by 20% since the previous quarter
The current ratio has dropped by 70% year-on-year and by 35% since the previous quarter
CNTX's debt is 99% smaller than its equity
The equity has dropped by 54% year-on-year and by 27% since the previous quarter
CNTX's debt is up by 46% year-on-year but it is down by 13% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.